MRNA vs PRIM · rev $1.94B vs P/E 22, rev $1.74B
Moderna Inc (MRNA) versus Primoris Services Corporation (PRIM) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Primoris Services Corporation (PRIM) is a engineering & construction company listed on NYSE.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported PRIM revenue for 2024-12-31 was $1.74B. Net income was $180.9M. Revenue was up 5.6% from 2024-09-30 to 2024-12-31. PRIM currently screens at market cap $5.52B and trailing P/E 22.4.
MRNA currently screens at market cap $24.52B. PRIM currently screens at market cap $5.52B and trailing P/E 22.4.
Not investment advice. Open the MRNA and PRIM stock pages for the full models.
Not investment advice.